Delivery Order SPE2DR25D2014-SPE2DR26FZ91C
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,986.33 to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (500 count) on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed price, competitively awarded delivery order represents a single pharmaceutical product shipment with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of CellCept 500 mg tablets (100-count units) with a ceiling value of $5,074.60. This is a firm fixed-price delivery order under an indefinite delivery contract vehicle, with an ultimate completion date of November 10, 2025. The contract was competitively awarded without set-aside designation to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $1,268.65 firm fixed-price delivery order for 100 tablets of CellCept 500 mg by the Defense Logistics Agency on December 8, 2025, with an ultimate completion date of December 9, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100-count units) under a firm fixed-price contract valued at $17,337.23. This non-set-aside award was issued on December 11, 2025, with an ultimate completion date of December 12, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a firm fixed-price delivery order valued at $34,182.88 for 100-count bottles of CellCept 500 mg tablets, with a completion date of December 3, 2025. This non-competitive delivery order was issued without a set-aside designation and represents a standard pharmaceutical procurement supporting military healthcare operations. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $17,869.02 delivery order on December 8, 2025, for the supply of CellCept 500 mg tablets (100-count units) with a completion date of December 9, 2025. This is a firm fixed-price, non-set-aside contract with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100 count) on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order has a ceiling value of $27,735.62 and carries no set-aside designation. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters as a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on May 2, 2025, for the supply of CellCept 500 mg tablets (100-count units) with a ceiling value of $2,987.17. The contract is a firm fixed-price delivery order with an ultimate completion date of May 5, 2025 and was competitively awarded with no set-aside designation. The award is funded by the Medical Supply Chain, a defense-oriented federal agency, with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $46,236.08 to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100 count) with a firm fixed price contract type. The award was made on November 18, 2025, with an ultimate completion date of November 19, 2025, and the product will be performed from the contractor's location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, demonstrating...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of CellCept 500 mg tablets (100-count units) with a ceiling value of $19,770.34. This firm fixed price delivery order, with an ultimate completion date of September 24, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ91CDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,587.31 to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (500-count) on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. CellCept is an immunosuppressant medication commonly used in transplant medicine and certain autoimmune conditions within military healthcare settings. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse pharmaceutical supply requirements across multiple therapeutic domains, with delivery orders consistently structured under firm fixed-price arrangements through the DLA Medical Supply Chain, which supports the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 12/7/25 |